Murray O Robinson

This inventor holds 16 USPTO granted patents and 4 published patent applications and 2 EPO patents. Top assignees: Amgen Inc., Aveo Pharmaceuticals, Inc., Amgen Canada Inc.. Active years: 1996-2018.

USPTO Granted Patents = 16 (Patent Applications = 4)

% Patents Active = 43.8

EPO Patents = 2 (Patent Applications = 8)

Average Co-Inventor Count = 3.1

ph-index = 5

Forward Citations = 116(Granted Patents)

Location History:

Malibu, CA (US) (1996 - 2008)
Cambridge, MA (US) (2008)
Boston, MA (US) (2009 - 2018)

Company Filing History:

Aveo Pharmaceuticals, Inc.

Osi Pharmaceuticals, Inc.

patents

5. 1 out of 834,307

Other

patents

where one patent can have more than one assignee

Years Active: 1996-2018

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9896730 - Use of EMT gene signatures in cancer drug discovery, diagnostics, and treatment (2018-02-20),

2. 9345788 - Reconstituted human breast tumor model (2016-05-24),

3. 8373017 - Reconstituted human breast tumor model (2013-02-12),

4. 7736861 - Tivozanib response prediction (2010-06-15),

5. 7622630 - Chimeric cancer models (2009-11-24),

6. 7615353 - Tivozanib response prediction (2009-11-10),

7. 7556796 - Directed complementation (2009-07-07),

8. 7455963 - Antibodies to cyclin E2 protein (2008-11-25),

9. 7390891 - Polynucleotides encoding a telomerase component TP2 (2008-06-24),

10. 6943238 - Antibodies to cyclin E2 protein (2005-09-13),

11. 6174703 - Genes encoding telomerase protein 1 (2001-01-16),

12. 6165753 - Cyclin E genes and proteins (2000-12-26),

13. 5981707 - Genes encoding telomerase protein 1 (1999-11-09),

14. 5973119 - Cyclin E genes and proteins (1999-10-26),

15. 5919656 - Genes encoding telomerase protein 1 (1999-07-06),

Title: The Innovative Genius of Murray O. Robinson

Introduction

Murray O. Robinson, based in Malibu, California, is an esteemed inventor whose contributions to the field of biotechnology are noteworthy. With a remarkable portfolio of nine patents, Robinson has made significant strides in understanding and manipulating molecular biology, particularly through his innovative work with nucleic acids and proteins.

Latest Patents

Among his latest contributions, Robinson has developed groundbreaking patents that focus on critical cellular components. One notable patent involves antibodies to the cyclin E2 protein, where he discloses nucleic acid molecules encoding cyclin E2 polypeptides. This patent also outlines methods for preparing both the nucleic acids and the polypeptides while detailing various applications of these molecules. Furthermore, he has patented polynucleotides encoding a telomerase component, TP2, thus broadening the understanding of the telomerase complex. This patent likewise includes methodologies for the preparation and use of these nucleic acid molecules and polypeptides.

Career Highlights

Robinson's professional journey has been marked by his tenure at reputable companies such as Amgen Inc. and Amgen Canada Inc. His work in these organizations has allowed him to explore and innovate in vital areas of biotechnology, facilitating advancements in health and disease treatment.

Collaborations

Throughout his career, Robinson has collaborated with esteemed colleagues, including Lea Anne Harrington and Steven Roy Coats. These partnerships have fostered a collaborative environment, enabling the exchange of ideas and the advancement of scientific knowledge in their field.

Conclusion

Murray O. Robinson stands out as a significant figure in the world of invention and biotechnology. His dedication to innovation is evident in his numerous patents, which continue to influence scientific research and development. As he progresses in his career, Robinson’s contributions are anticipated to have a lasting impact on the scientific community and beyond.